Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
about
Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized miceEngineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT miceIn vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cellsAntiviral restriction factor transgenesis in the domestic catRNA-guided human genome engineering via Cas9Stem-cell-based gene therapy for HIV infectionTargeted DNA mutagenesis for the cure of chronic viral infectionsNewer gene editing technologies toward HIV gene therapyAnimal Models for HIV Cure ResearchGenome-editing Technologies for Gene and Cell TherapyTowards a new era in medicine: therapeutic genome editingApplication of CRISPR/Cas9 Technology to HBVFrom Gene Targeting to Genome Editing: Transgenic animals applications and beyondEnabling functional genomics with genome engineeringHematopoietic Stem and Immune Cells in Chronic HIV InfectionProgress toward curing HIV infection with hematopoietic cell transplantationBone Marrow Gene Therapy for HIV/AIDSStudies of retroviral infection in humanized miceImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoPre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized miceCan immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Combinatorial RNA-based gene therapy for the treatment of HIV/AIDSExpanding the scope of site-specific recombinases for genetic and metabolic engineeringHematopoietic stem cell engineering at a crossroadsRecent developments in human immunodeficiency virus-1 latency researchNovel approaches to inhibit HIV entryNew generation humanized mice for virus research: comparative aspects and future prospectsGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceTargeted gene disruption to cure HIVAnemia: progress in molecular mechanisms and therapiesHematopoietic-stem-cell-based gene therapy for HIV diseaseCurrent translational and clinical practices in hematopoietic cell and gene therapyGenome editing: the road of CRISPR/Cas9 from bench to clinicStem cell transplantation in strategies for curing HIV/AIDSUsing animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchTherapeutic genome editing: prospects and challengesBacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentGene editing of CCR5 in autologous CD4 T cells of persons infected with HIVEnhancing zinc-finger-nuclease activity with improved obligate heterodimeric architecturesRepair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells
P2860
Q21090483-9E52B543-5FC3-4A74-90AF-A4AF72EBEBBEQ21133769-301F5EA7-B2A1-4681-B6A9-47FB815AA1DDQ21559398-4ED6A0D2-80F1-47FE-ACAB-02885E5E510AQ24567554-A9FA11DE-EC11-46CD-845F-A41D5A01EC6CQ24598394-B3B349C7-A4CF-41A4-9C77-710B1127F9E1Q24607667-EAFFB2FF-E443-4FC7-82FD-5A4D61CB48A0Q24620150-45873CA0-72AB-49C1-B6F2-5B3797A76E9BQ24631042-F8964ADD-23E3-4F45-8CF2-32304C1115D2Q26767476-D52238F9-877A-4894-99DC-E72BC10CE08EQ26769662-3B1BFB90-BBDC-4BB6-BE95-98D4D8C7BCC3Q26773287-321C5B2B-C2AE-491B-B351-39408A02C0B7Q26779150-0A262152-9D21-43F4-A272-E29338AC9095Q26781859-16D97B4D-B1BC-4430-898C-FCED048004B9Q26782747-EF28B426-0CB1-4BAF-83EB-46390B3FFFDEQ26795450-34074E08-CB1A-40D4-B7C4-EC003AEBBB39Q26801269-16ACA4CA-30B3-4561-BA01-22982A5432F7Q26801765-DB42D12F-BF2D-409B-9F66-DAFDE243BE78Q26849806-EE82D524-B991-45D5-87BC-83877130C81CQ26851152-2A77B6DF-B344-42B9-9312-4F533304A47DQ26862954-D173E8CF-B08E-49ED-96E8-7138F0A00112Q26865388-2B4FAD41-F5A6-4CD2-A066-32EF3FCB69E0Q26866145-E5833E94-E1EA-44F6-8A6C-5BAC3E76A202Q26995224-D5460747-23D2-4508-BE32-49DEDDC77FD3Q27001570-4CE05066-282D-4501-B35E-E94433FDF963Q27013114-E34EFC8A-A356-4A6E-91AD-00D88E60A39AQ27013957-595497F6-8540-40D8-A721-4BA84B5AC0F0Q27014786-2F09DCBB-6527-4F90-8CC1-B765B54C3014Q27022347-AB72C6F0-2EF1-4AD9-8142-202BC45B4A22Q27023171-1E15FB07-4A28-449B-9B7F-F5D991F40168Q27023172-98BDDEFD-41CA-400E-BB9F-2ECCD98D1635Q27023434-50BCE79A-4BBA-405E-8B7C-73DA6DDE6E39Q27024456-B9706F76-DDBB-4F9B-8702-BB7BF9FCC4CBQ28066970-2C7603CF-2F77-47BE-94F7-D5C0EE454BABQ28069423-2C026BC4-9FBC-4038-81CF-CF74FDE45166Q28077662-313A29E6-3BE9-49E9-B4EB-E5FFC656EF32Q28087380-60787771-1EA4-4C7B-9C23-6414FF447879Q28087526-3F155501-9724-49FF-B224-55D9A61A6773Q28235281-42BA5FBE-31C8-4D33-AA9B-FCF756DE2035Q28299915-97BFF273-20FC-4E91-AB67-054FBE044AFBQ28478289-03C95C19-5837-48EC-A622-D4538432E1EC
P2860
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@ast
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@en
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@nl
type
label
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@ast
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@en
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@nl
prefLabel
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@ast
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@en
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Human hematopoietic stem/proge ...... to CCR5 control HIV-1 in vivo.
@en
P2093
Gay M Crooks
Geoffrey Friedman
Jianbin Wang
Kenneth Kim
Michael C Holmes
Nathalia Holt
Paula M Cannon
Vanessa Taupin
Xingchao Wang
P2860
P2888
P304
P356
10.1038/NBT.1663
P577
2010-07-02T00:00:00Z